- Does modum.io already have a product and with a well-established business case?
modum.io has a working temperature logger prototype, which was used to track shipments in several pilot projects within Europe and the Middle East. modum.io is currently launching the first generation of its own, proprietary sensor device based on findings from each pilot. Our go-to-market strategy is regulatory driven, based on new requirements placed on the pharma industry. We are currently working with academic and industry partners as well as clients.
- How was modum.io’s first business case developed?
The European Commission has recently released tightened regulatory requirements for the transport of medicinal products for human use.modum.io’s first targeted solution offers an efficient system for distributors to comply with these regulatory requirements.
- What are the regulatory changes driving modum’s first product?
Chapter nine of the Good Distribution Practice regulation (GDP 2013/C 343/01) now requires proof that shipped medicinal products have not been exposed to conditions (particularly temperature) that may have compromised their quality.
- How does the modum solution achieve GDP compliancy for its clients?
To date, pharmaceutical companies achieve compliance with regulatory requirements by using expensive, temperature-stabilized trucks and containers from third-party logistics providers (3PLs). modum.io offers a more efficient supply-chain solution, which enables companies to prove compliance with GDP regulations by using blockchain and Internet-of-Things (IoT) technology.
- What is the business potential of the modum solution?
By using the modum solution, costs per shipment can be reduced by up to 60%. With respect to the 200 million shipments of pharmaceutical products in the EU, a widespread adoption of the modum system has the potential to reduce industry-wide expenses of approximately 3 billion EUR annually.
- What is modum.io’s go-to market strategy?
Currently, the modum system is being integrated into the system of the leading last-mile logistics service provider in Switzerland. modum.io is planning to finalize this integration in Q4/2017. Upon successful completion, official market entry will begin in Q1/2018.
- What is modum.io’s vision for growing its platform for expanded service delivery?
modum.io, with its system and first business case, eagerly anticipates horizontal and vertical growth by evolving the developed system. Low-cost and low-power IoT sensors have become commonplace for:
- Light/machine vision
- Flow (Liquid)
Modum.io foresees adding sensor devices with these capabilities to build a platform for IoT monitoring in supply chain across a variety of sectors.
- Into which sectors could the modum system be expanded?
With the experience gained from the high standards and low-cost requirements set by the pharma industry, the modum system will be well positioned to be deployed in other sectors. modum.io has been approached by leading companies from the following sectors, each of which have overlapping needs with the solutions laid out in our first use case:
modum.io has been approached by Healthcare institutions to improve their processes (internal and multi-stakeholder) using IoT and blockchain technology.
Customers from the chemical industry have similar needs to pharma customers, requiring compliance with similar regulations. Data integrity is an issue, causing customers from the chemical industry to perform more extensive post-delivery checks on their chemicals than they would deem necessary.
Machine building companies need accountability during transport of their high-value components, requiring traceable data for acceleration (shock) and humidity (storage and transport conditions).
- Automotive, Aerospace and Aviation
The automotive, aerospace, and aviation industry needs efficient and auditable systems to prove the authenticity of every single component. Constant performance checks of essential parts serve to reduce liabilities in case of accidents.
Pharma standards and regulations for food safety are closely related, in the United States they are supervised by the same government agency, the FDA. Customers from the food sector are additionally looking into improving their processes, providing traceable data in order to market the origin and the quality of their products.
- What are the USP/functions of the modum system?
Before shipment occurs, the modum sensor device ID, shipment ID, and alarm criteria are fixed within a shipment-specific smart contract. Upon receipt, this smart contract will allow the receiver to check that regulations have been met. Due to the nature of a smart contract in the blockchain, the evaluation criteria for meeting regulations cannot be changed retroactively.
During the shipment, the change of environmental conditions (i.e. temperature, humidity, movement, etc.), is monitored and the data is stored in the internal flash memory of the sensor device. Using BLE (Bluetooth Low Energy), the shipment does not need to be opened to verify the shipment has complied with the environmental parameters set. At each change of ownership, data authenticity is first checked by the smart contract before it is evaluating the data. The results of the evaluation are then stored, immutably, as proof-of-existence in a blockchain.
- Do customers need to install additional hardware?
No, customers do not need to install additional hardware to use the system, downloading our mobile application is sufficient. The modum system is also compatible with every other BLE device.
- How does modum.io generate revenue?
modum.io will offer its solution in a “pay per shipment” model to pharma producers and wholesaler. During modum.io’s extensive proof-of-concept phase, pilot projects with several customers determined that the modum solution delivered the highest value as a service in last-mile logistics of an overall pharma supply chain. In the EU, more than 200 million of these last-mile shipments occur each year.
- Does modum.io have any strategic Partnerships?
Yes, modum.io has several partnerships. We are working with the market leader in parcel services in Switzerland, the owner of Europe’s leading mail order pharmacy, two leading pharma wholesaler and the University of Zurich and the University of St. Gallen.